Follow
Moritz Hundertmark
Moritz Hundertmark
Oxford Centre for Clinical Magnetic Resonance Research
Verified email at cardiov.ox.ac.uk - Homepage
Title
Cited by
Cited by
Year
Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies
S Frantz, MJ Hundertmark, J Schulz-Menger, FM Bengel, J Bauersachs
European heart journal 43 (27), 2549-2561, 2022
1792022
Energetic basis for exercise-induced pulmonary congestion in heart failure with preserved ejection fraction
MK Burrage, M Hundertmark, L Valkovič, WD Watson, J Rayner, ...
Circulation 144 (21), 1664-1678, 2021
582021
Cardiac energetics in patients with aortic stenosis and preserved versus reduced ejection fraction
MA Peterzan, WT Clarke, CA Lygate, HA Lake, JYC Lau, JJ Miller, ...
Circulation 141 (24), 1971-1985, 2020
272020
Design and rationale of the EMPA‐VISION trial: investigating the metabolic effects of empagliflozin in patients with heart failure
MJ Hundertmark, OF Agbaje, R Coleman, JT George, R Grempler, ...
ESC Heart Failure 8 (4), 2580-2590, 2021
242021
Assessment of cardiac energy metabolism, function, and physiology in patients with heart failure taking empagliflozin: the randomized, controlled EMPA-VISION trial
MJ Hundertmark, A Adler, C Antoniades, R Coleman, JL Griffin, ...
Circulation 147 (22), 1654-1669, 2023
222023
Localized rest and stress human cardiac creatine kinase reaction kinetics at 3 T
WT Clarke, MA Peterzan, JJ Rayner, RA Sayeed, M Petrou, ...
NMR in Biomedicine 32 (6), e4085, 2019
212019
Quantifying the effect of dobutamine stress on myocardial Pi and pH in healthy volunteers: A 31P MRS study at 7T
A Apps, L Valkovič, M Peterzan, JYC Lau, M Hundertmark, W Clarke, ...
Magnetic Resonance in Medicine 85 (3), 1147-1159, 2021
152021
Eya4 Induces Hypertrophy via Regulation of p27kip1
T Williams, M Hundertmark, P Nordbeck, S Voll, PA Arias-Loza, D Oppelt, ...
Circulation: Cardiovascular Genetics 8 (6), 752-764, 2015
112015
Capnocytophaga canimorsus as cause of fatal sepsis
M Hundertmark, T Williams, A Vogel, M Moritz, P Bramlage, N Pagonas, ...
Case reports in infectious diseases 2019, 2019
92019
Association between sarcomeric variants in hypertrophic cardiomyopathy and myocardial oxygenation: insights from a novel oxygen-sensitive cardiovascular magnetic resonance approach
B Raman, EM Tunnicliffe, K Chan, R Ariga, M Hundertmark, EO Ohuma, ...
Circulation 144 (20), 1656-1658, 2021
52021
A phase 2a trial investigating ninerafaxstat–a novel cardiac mitotrope for the treatment of diabetic cardiomyopathy (IMPROVE-DiCE)
M Hundertmark, AG Siu, V Matthews, AJ Lewis, JT Grist, J Patel, ...
European Heart Journal 43 (Supplement_2), ehac544. 246, 2022
42022
Should CMR be the default imaging modality in clinical trials for heart failure?
M Hundertmark
Cardiovascular diagnosis and therapy 10 (3), 554, 2020
42020
Diagnosing post-capillary hypertension in patients with left heart disease: impact of new guidelines
G Güder, T Reiter, G Fette, M Hundertmark, S Frantz, C Morbach, S Störk, ...
Clinical Research in Cardiology, 1-10, 2023
22023
143 Measuring pcr/atp as a marker of myocardial energetics across the spectrum of metabolic cardiac disease
JA Henry, E Levelt, J Rayner, M Hundertmark, M Peterzan, P Green, ...
Heart 108 (Suppl 1), A109-A110, 2022
22022
Diabetes mellitus and heart failure: insights from a toxic relationship
M Hundertmark, E Wicks
Practical Diabetes 35 (4), 112-116b, 2018
22018
Intentional Weight Loss as a Novel Treatment for Heart Failure with Preserved Ejection Fraction
MJ Hundertmark, M Burrage, J Miller, W Watson, M Peterzan, J Rayner, ...
Circulation 144 (Suppl_1), A11064-A11064, 2021
12021
Comparison of human cardiac 31P-MRS on 3TTrio and Prisma scanners
J Ellis, M Hundertmark, M Spartera, W Watson, CT Rodgers, L Valkovic
Proc. ISMRM, 2019
12019
Ninerafaxstat Modulates Cardiac Energy Metabolism in Cardio-metabolic Syndromes: A Mechanistic, Hyperpolarized MR Trial
M Hundertmark, O Rider, J Patel, D Tyler, P Chamberlin, J Miller, ...
Journal of Cardiovascular Magnetic Resonance 26, 2024
2024
Compartment-based reconstruction of acquisition-weighted 31P cardiac MRSI reduces sensitivity to cardiac motion and scan planning
A Tyler, MJ Hundertmark, JJ Miller, O Rider, DJ Tyler, L Valkovič
Frontiers in Physiology 14, 1325458, 2024
2024
Modulating Cardiac Energetics in Cardio-Metabolic Syndromes: A mechanistic, hyperpolarized MR Trial of Ninerafaxstat Treatment
MJ Hundertmark, AG Siu, V Matthews, AJM Lewis, JT Grist, J Patel, ...
bioRxiv, 2024.04. 24.591019, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–20